These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3138577)

  • 1. Differential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood.
    Eckland DJ; Todd K; Jessop DS; Biswas S; Lightman SL
    Neurosci Lett; 1988 Aug; 90(3):292-6. PubMed ID: 3138577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.
    Guillaume V; Conte-Devolx B; Szafarczyk A; Malaval F; Pares-Herbute N; Grino M; Alonso G; Assenmacher I; Oliver C
    Neuroendocrinology; 1987 Aug; 46(2):143-6. PubMed ID: 2819759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotrophin-releasing factor and arginine vasopressin in the hypothalamo-hypophyseal portal blood of rats following high-dose glucocorticoid treatment and withdrawal.
    Eckland DJ; Harbuz MS; Jessop DS; Lightman SL
    Brain Res; 1991 Dec; 568(1-2):311-3. PubMed ID: 1814575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA; Fink G; Sheward WJ
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.
    Sheward WJ; Fink G
    J Endocrinol; 1991 Apr; 129(1):91-8. PubMed ID: 2030334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.
    Chowdrey HS; Larsen PJ; Harbuz MS; Jessop DS; Aguilera G; Eckland DJ; Lightman SL
    Br J Pharmacol; 1995 Nov; 116(5):2417-24. PubMed ID: 8581278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.
    Fink G; Robinson IC; Tannahill LA
    J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine on the hypothalamo-pituitary-adrenocortical axis.
    Nicholson S; Holmes M; Sutanto W; Watts S; Campbell E; Gillham B; Jones M
    Neuroendocrinology; 1986; 43(4):483-90. PubMed ID: 3018609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampus.
    Tannahill LA; Sheward WJ; Robinson IC; Fink G
    J Endocrinol; 1991 Apr; 129(1):99-107. PubMed ID: 2030335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood.
    Tannahill LA; Dow RC; Fairhall KM; Robinson IC; Fink G
    Neuroendocrinology; 1988 Dec; 48(6):650-7. PubMed ID: 2855106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central catecholaminergic system stimulates secretion of CRH at different sites.
    Szafarczyk A; Guillaume V; Conte-Devolx B; Alonso G; Malaval F; Pares-Herbuté N; Oliver C; Assenmacher I
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E463-8. PubMed ID: 2845801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of oxytocin secretion by ascending noradrenergic pathways: sexual dimorphism in rats.
    Carter DA; Lightman SL
    Brain Res; 1987 Mar; 406(1-2):313-6. PubMed ID: 3105813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats.
    Alonso G; Szafarczyk A; Balmefrézol M; Assenmacher I
    Brain Res; 1986 Nov; 397(2):297-307. PubMed ID: 3099973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin.
    Plotsky PM; Bruhn TO; Vale W
    Endocrinology; 1984 Oct; 115(4):1639-41. PubMed ID: 6332731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of corticotropin releasing factor (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams.
    Caraty A; Grino M; Locatelli A; Oliver C
    Biochem Biophys Res Commun; 1988 Sep; 155(2):841-9. PubMed ID: 3048263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypothalamic norepinephrine depletion on median eminence CRF-41 content and serum ACTH in control and adrenalectomized rats.
    Weidenfeld J; Feldman S
    Brain Res; 1991 Mar; 542(2):201-4. PubMed ID: 1851452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion.
    Lightman SL; Todd K; Everitt BJ
    Exp Brain Res; 1984; 55(1):145-51. PubMed ID: 6745345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.